Saturday, April 29, 2017

More than a million patients flock to this website. Drug companies are in hot pursuit. - The Washington Post

The Washington Post
Democracy Dies in Darkness

Brian Banks
Brian Banks
Log out
Newsletters & Alerts
Gift Subscriptions
Contact Us
Help Desk
Home Page U.S. & World | Regional
Newsletters & Alerts
Washington Post Live
Live Chats
Real Estate
WP BrandStudio
1996-2017 The Washington Post
Terms of Service
Privacy Policy
Submissions and Discussion Policy
RSS Terms of Service
Ad Choices

Business Perspective
More than a million patients flock to this website. Drug companies are in hot pursuit.

Inspire chief executive Brian Loew's nine-year-old medical-website business, based in Arlington, has 1.1 million members, 33 employees, nearly $10 million in revenue and will turn its first profit this year. (J. Lawler Duggan/For The Washington Post)

By Thomas Heath Reporter April 28
This isn't Brian Loew's first run at Internet success.

During the thick of the dot-com mania 20 years ago, Loew and some friends built an online publishing company called It had 150 employees and $15 million in revenue but, like many start-ups from the era, it never posted a profit. created website software in the Internet's early days for Elle, Car and Driver, the ill-fated George magazine and other publications.

"I was going to be rich beyond my wildest dreams," Loew said, recounting what his bankers had told him at the time.

Ten days away from the company's initial public offering, the go-go, dot-com age imploded and Loew's path to riches vaporized. The company, which bankers predicted could eventually be worth $1 billion, was sold off for a small fraction of that.

"Investors got their money back, but nobody got rich," Loew said.

The 46-year-old entrepreneur appears to be on to something with a better future this time around. His nine-year-old medical-website business, known as Inspire, has 1.1 million members, 33 employees and nearly $10 million in revenue, and it will turn its first profit this year.

Inspire essentially is a giant, online discussion community where people can use real or assumed names to share experiences, information and advice about their various medical conditions.

"Join many others who understand what you're going through and are making important decisions about their health," says the greeting on Inspire's website.

[Trump calls for lower drug prices, fewer regulations in meeting with pharmaceutical executives]

Loew and his company are attached to the surge of patient assertiveness, with more people questioning their health care and taking more of the responsibility out of the hands of professionals.

"Patient centricity really matters," said Loew, who owns a big chunk of the company, along with investors and employees.

Membership is free and increasing by 1,000 per day. Seventy-eight percent of members are women.

"Women are the chief medical officers of the home," Loew said. "Many of our female members represent a member of the family — husbands, fathers, fathers-in-law, siblings, children. So sometimes a woman would join and say, 'I'm a parent of a 'preemie,' a child of someone with a medical condition, a sister of someone else.' "

The company has a team of community moderators to make sure members get along on chats.

Revenue comes from advertising and from companies looking for hard-to-find patients to participate in clinical drug trials or market research.

Many of the research contracts come from pharmaceutical giants to carry out drug trials or marketing studies on everything from psoriasis (one of the most common ailments among members) to cancer. The contracts can pay anywhere from $50,000 to $750,000, Loew said. It usually amounts to about $1,000 per patient for market research and up to $10,000 for clinical trials.

Inspire's clients include the top 10 pharmaceutical companies in the world, as well as most of the top 25.

"It matters to these companies what patients think and want and how they make decisions," Loew said.

Inspire doesn't advertise to promote itself. It gets exposure from many of its nonprofit-organization partners, such as the American Lung Association, the National Psoriasis Foundation and the Arthritis Foundation. Some members come from posting specific medical terms on Google search, which brings them to Inspire.

[House Freedom Caucus leaders back new health-care plan]

While revenue is split evenly between advertising and research projects, Loew said that there is more upside in research.

One quarter of Inspire's members, or about 250,000 people, are afflicted with rare diseases. They use online searches to find people facing similar challenges. The pool includes people who suffer from relatively rare maladies such as Wilson's disease, pulmonary fibrosis and pancreatic neuroendocrine tumor or PNET, which killed Apple co-founder Steve Jobs. A large concentration of PNET sufferers are on Inspire.

The site also has 40,000 members in the community of Ehlers-Danlos syndrome, which is a disorder of the tissue surrounding joints.

"What that means is that if you are a researcher trying to study these things, you have trouble finding patients," Loew said. "And we have the patients. The researcher comes to us and we invite the member to participate."

Getting people to open up to researchers is handled delicately. (I confess to a certain unease when it comes to personal health issues online, even though I have written about them for this newspaper.)

Loew said the key is honesty and transparency when approaching members about participating in studies: "Particularly when someone is sick, it's important that they think they are in control. A lot of people are being asked these questions at their most vulnerable moment."

Loew said Inspire emails members, notifying them of a study, describing what it is and informing them how to participate if they would like. "And if they don't respond, we ask more people," he said. "No means no."

If the patient wants to connect with the researcher, Inspire helps them meet and then steps out of the way.

The clients can get pretty specific about what they need. One pharmaceutical company came to Inspire for help in locating hemophilia Type B patients. The search had been going on for two years. Inspire found the patients in two weeks from its membership.

Loew has always had a science bent. He grew up in an upper-middle-class family in Fairfax County. His mother taught elementary school and his father still teaches biomedical engineering at George Washington University.

Loew received his first computer at age 10. He attended the prestigious Thomas Jefferson High School for Science and Technology, then double-majored in physics and economics at GWU.

[This doctor's tool kit includes a remedy from the past: House Calls]

After graduating in 1993, he wrote computer code at the World Bank, then worked for Nature, the British science journal. He and some friends started in 1993. The entire arc of the company, including the sell-off in 2000, left him depressed.

"We were so close to going public, and then the world changed," he said, looking back.

He was hired by The Washington Post to help with technology strategy.

The idea for Inspire was born at a 2005 event sponsored by the pharmaceutical industry, in which Loew's wife, an organic chemist, was employed. Several people at the event were in the research-and-development end of the drug business.

"These R&D companies with gigantic budgets described their biggest problem as recruiting patients for clinical trials," he said. "Privacy in America makes it appropriately illegal to buy lists of patients."

A lightbulb went off, he said: "What if you create a social network for patients and caregivers and allow them to raise their hands if they want to participate in clinical trials?"

Economy & Business Alerts
Breaking news about economic and business issues.
Sign up
Loew wrote a business plan to build a website with communities of patients organized by issues: prostate cancer; lung cancer; psoriasis; infertility; preemies.

"The idea was to create a safe, supportive community for patients to gather. If you were diagnosed with something serious," he said, "we knew a community could help with those things. Patients seek other patients to get support and compare notes."

Inspire now inhabits a 6,000-square-foot office in Arlington. Loew expects it to turn its first profit this year.

And It lives on. Some former employees bought the company back. To this day, it writes the secure, daily briefing for the Joint Chiefs of Staff.

Read more:

These health care entrepreneurs try to keep win streak going

The dentist who became one of the richest people in Washington

A boring business that Warren Buffett would love

Share on FacebookShare
Share on TwitterTweet
Share via Email

Thomas Heath is a local business reporter and columnist, writing about entrepreneurs and various companies big and small in the Washington Metropolitan area. Previously, he wrote about the business of sports for The Post's sports section for most of a decade. Follow @addedvalueth
The Post Recommends

This brutal new poll shows that fewer and fewer people believe Trump's lies
Lies, lies and more lies. And Americans know it.

Trump has galvanized activists on the left. Can they stay energized?
Thousands of groups have sprouted across the country, aimed at resisting the president's agenda.

Kathleen and Hunter Biden's divorce is final, report says
The son of the former vice president is now in a relationship with his brother's widow.

A Monster Performer for This Class of Laptop: Get the Dell XPS 15
A Monster Performer for This Class of Laptop: Get the Dell XPS 15
Windows Central
'SNL' under fire for Kellyanne Conway sketch'SNL' under fire for Kellyanne Conway sketch
'SNL' under fire for Kellyanne Conway sketch
ABC News
Learn the Importance of Having an Estate Plan in Place
Learn the Importance of Having an Estate Plan in Place
Wells Fargo
Homeowners Born Before 1985 Get A Huge Surprise
Homeowners Born Before 1985 Get A Huge Surprise
Painful Periods due to Endometriosis Pain? Learn About an Upcoming Research Study
Painful Periods due to Endometriosis Pain? Learn About an Upcoming Research Study
Equinox Study
Aging Without Wrinkles: 6 Ways to Revitalize Skin
Aging Without Wrinkles: 6 Ways to Revitalize Skin
Diet Doc
Recommended by
Discussion Policy 5 Comments

Mentioned in this story and want to comment? Click here
Brian Banks

What's on your mind?
All Comments
Newest First
Pause live updates
9:25 AM CDT
My wake up call about the state of the so called medical establishment was a fine book, Ending Medical Reversal. Two notable doctors wrote in with input from many Physicians . The two authors are, Vinatak Prasad, and Adam Cifu. With the medical profession and pharma's history of lets do this it should work, to the new drumbeat, nothing should happen, without evidence based trials a whole new world faces patients. The internet has opened up a way for people to do their own research, and not simply proceed with one treatment or instructions.
Ignore UserLikeReportReplyShare
6:50 AM CDT
It's an interesting idea. Cross between patient support and education and hooking potential subjects up with research. I understand that fully half of current research is in the field of medicine/health, probably because that's where the revenue potential is. I'd be very careful about the possibility of exploitation. Doesn't sound like the founder is too concerned, however. He's mainly in it for the wealth.
Ignore UserLikeReportReplyShare
6:12 AM CDT
FDA? Walk to work.
Ignore UserLikeReportReplyShare
4/28/2017 9:32 AM CDT
What a great concept! And keeping a barrier in place between the drug companies and the potential patients is Inspired. It makes the whole thing work for everybody. Congratulations, and I hope it makes a lot of money.
Ignore UserLikeReportReplyShare1
6:48 AM CDT
Not much of a barrier, I think.
Ignore UserLikeReportReply
Most Read
EPA website removes climate science site from public view after two decades
The most common reason people quit their $200,000 tech jobs
At 100 days, Trump's big talk on the economy lacks substance
Trump really needs an economic boom. So far, he's not getting one.
Heineken to Pepsi: Hold my beer
The story must be told.
Subscribe to The Washington Post.
Market Watch
DJIA -0.19% NASDAQ -0.02%

Co. name or symbol
Get quote
Last Update: 04/29/2017(DJIA&NASDAQ)
© 1996-2017 The Washington Post

Help and Contact Us
Terms of Service
Privacy Policy
Print Products Terms of Sale
Digital Products Terms of Sale
Submissions and Discussion Policy
RSS Terms of Service
Ad Choices

No comments: